The information in the cancer of the large bowel information centre is based on the Cancerbackup booklet, Understanding cancer of the large bowel, which was produced in accordance with the following sources and guidelines:
- Improving Outcomes in Colorectal Cancer – Manual Update. National Institute for Clinical Excellence, 2004.
- Full Guidance on the Use of Irinotecan, Oxaliplatin and Raltitrexed for the Treatment of Advanced Colorectal Cancer. National Institute for clinical Excellence, June 2003.
- Colorectal Cancer – Laparascopic Surgery (No 17). National Institute for Clinical Excellence, November 2003.
- Full Guidance on the Use of Capecitabine and Tegafur With Uracil for Metastatic Colorectal Cancer. National Institute for Clinical Excellence, May 2003.
- Guidance for the Management of Colorectal Cancer. Royal College of Surgeons and Association of Coloproctology of Great Britain and Ireland, 1996.
- Management of Colorectal Cancer: A National Clinical Guideline. Scottish Intercollegiate Guidelines Network, March 2003.
- Colorectal Cancer: A Guide to Therapy. H Beilberg et al. Martin Duntz, 2002.
- Gastrointestinal Oncology: Principles and Practice. D Kelson et al. Lippincott Williams and Wilkins, 2002.
- Cetuximab (Erbitux®) for Colorectal Cancer - Merck Pharmaceuticals Ltd 07 March 2005. Scottish Medicines Consortium, 2005.
- Appraisal Consultation Document: Colon Cancer (Adjuvant) - Capecitabine & Oxaliplatin . National Institute for Clinical Excellence, October 2005
Guidelines are constantly being updated and those noted above may have been revised since the booklet was produced. You can access up-to-date guidelines in the health professionals section of the website.
Content last reviewed: 01 July 2006
Page last modified: 26 October 2007
Via: http://www.cancerbackup.org.uk
Page last modified: 26 October 2007
Via: http://www.cancerbackup.org.uk
No comments:
Post a Comment